| Medical and Health Sciences | Lifetime | 54 | US 30 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 8 | US 6 | 100.00 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 5 | US 1 | 99.97 |
| Epidemiology | Lifetime | 125 | US 66 | 99.82 |
| Surgery | Lifetime | 262 | US 149 | 99.77 |
| Medical Physiology | Lifetime | 290 | US 165 | 99.53 |
| Pediatrics, Perinatology and Child Health | Lifetime | 218 | US 104 | 99.37 |
| Cardiology and Cardiovascular Medicine | Lifetime | 353 | US 203 | 99.54 |
| Public, Environmental and Occupational Health | Lifetime | 553 | US 277 | 99.23 |
| Obstetrics and Gynecology | Lifetime | 127 | US 63 | 99.23 |
| Rheumatology | Lifetime | 354 | US 159 | 98.50 |
| Pharmacy | Lifetime | 250 | US 134 | 96.94 |
| Pathology and Forensic Medicine | Lifetime | 985 | US 447 | 94.93 |
| Reproductive Medicine | Lifetime | 702 | US 334 | 92.88 |
| Nephrology | Lifetime | 791 | US 367 | 87.81 |
| Endocrine and Autonomic Systems | Lifetime | 671 | US 332 | 85.57 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 7 | US 5 | 99.96 |
| Medical Physiology | 2021-2025 | 11 | US 6 | 99.83 |
| Surgery | 2021-2025 | 66 | US 28 | 99.59 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 89 | US 47 | 99.62 |
| Epidemiology | 2021-2025 | 110 | US 31 | 99.31 |
| Public, Environmental and Occupational Health | 2021-2025 | 130 | US 53 | 98.91 |
| Rheumatology | 2021-2025 | 140 | US 39 | 96.88 |
| Clinical Pharmacology | 2021-2025 | 134 | US 41 | 95.45 |
| Nephrology | 2021-2025 | 202 | US 73 | 89.74 |
| Genetics | 2021-2025 | 455 | US 171 | 87.73 |
| Infectious Diseases | 2021-2025 | 613 | US 230 | 86.15 |
| Diabetes Treatment and Management | Lifetime | 4 | US 2 | 99.96 |
| Birth, Development, and Health | Lifetime | 17 | US 5 | 99.88 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 8 | US 4 | 99.95 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 12 | US 8 | 99.91 |
| COVID-19 Clinical Research Studies | Lifetime | 33 | US 9 | 99.72 |
| Lipoproteins and Cardiovascular Health | Lifetime | 14 | US 9 | 99.88 |
| Cardiovascular Disease and Adiposity | Lifetime | 23 | US 17 | 99.82 |
| Diabetes Management and Research | Lifetime | 39 | US 23 | 99.76 |
| Gestational Diabetes Research and Management | Lifetime | 22 | US 11 | 99.71 |
| Metabolism, Diabetes, and Cancer | Lifetime | 39 | US 21 | 99.77 |
| Diet and metabolism studies | Lifetime | 91 | US 42 | 99.75 |
| Liver Disease Diagnosis and Treatment | Lifetime | 132 | US 53 | 99.77 |
| Pregnancy and preeclampsia studies | Lifetime | 72 | US 26 | 99.56 |
| Cardiovascular Function and Risk Factors | Lifetime | 179 | US 115 | 99.63 |
| Long-Term Effects of COVID-19 | Lifetime | 99 | US 25 | 98.82 |
| Cancer, Lipids, and Metabolism | Lifetime | 134 | US 76 | 99.35 |
| Chronic Disease Management Strategies | Lifetime | 79 | US 35 | 99.14 |
| Diet, Metabolism, and Disease | Lifetime | 141 | US 62 | 99.07 |
| Bariatric Surgery and Outcomes | Lifetime | 71 | US 41 | 98.82 |
| Obesity and Health Practices | Lifetime | 60 | US 42 | 99.10 |
| Pancreatic function and diabetes | Lifetime | 284 | US 131 | 99.04 |
| Pharmacology and Obesity Treatment | Lifetime | 63 | US 33 | 99.03 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 40 | US 9 | 98.79 |
| Heart Failure Treatment and Management | Lifetime | 204 | US 109 | 99.19 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 146 | US 73 | 98.79 |
| Obesity, Physical Activity, Diet | Lifetime | 385 | US 173 | 99.03 |
| Systemic Lupus Erythematosus Research | Lifetime | 361 | US 138 | 98.82 |
| Nutrition and Health in Aging | Lifetime | 409 | US 161 | 98.45 |
| Lipid metabolism and disorders | Lifetime | 146 | US 60 | 98.12 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 344 | US 97 | 98.51 |
| Health, Environment, Cognitive Aging | Lifetime | 145 | US 70 | 97.64 |
| COVID-19 and healthcare impacts | Lifetime | 396 | US 159 | 95.28 |
| Blood Pressure and Hypertension Studies | Lifetime | 658 | US 275 | 98.14 |
| Biomarkers in Disease Mechanisms | Lifetime | 91 | US 27 | 96.08 |
| Regulation of Appetite and Obesity | Lifetime | 397 | US 185 | 97.66 |
| Diabetes and associated disorders | Lifetime | 753 | US 291 | 97.39 |
| Genetic Associations and Epidemiology | Lifetime | 454 | US 215 | 97.62 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 250 | US 47 | 95.02 |
| Nutritional Studies and Diet | Lifetime | 762 | US 301 | 97.61 |
| Vitamin D Research Studies | Lifetime | 428 | US 188 | 97.07 |
| Acute Myocardial Infarction Research | Lifetime | 807 | US 334 | 97.65 |
| Ovarian function and disorders | Lifetime | 658 | US 244 | 97.26 |
| Cardiovascular Health and Risk Factors | Lifetime | 303 | US 180 | 96.06 |
| Diabetes Management and Education | Lifetime | 522 | US 242 | 95.42 |
| Spondyloarthritis Studies and Treatments | Lifetime | 631 | US 110 | 94.34 |
| GDF15 and Related Biomarkers | Lifetime | 268 | US 98 | 88.07 |
| Dietary Effects on Health | Lifetime | 761 | US 316 | 88.84 |
| Diet and metabolism studies | 2021-2025 | 5 | US 4 | 99.90 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 3 | US 2 | 99.88 |
| Diabetes Treatment and Management | 2021-2025 | 7 | US 6 | 99.93 |
| Diabetes Management and Research | 2021-2025 | 8 | US 6 | 99.85 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 6 | US 3 | 99.70 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 69 | US 21 | 99.57 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 56 | US 31 | 99.63 |
| Pancreatic function and diabetes | 2021-2025 | 32 | US 20 | 99.06 |
| Pharmacology and Obesity Treatment | 2021-2025 | 6 | US 4 | 99.11 |
| Obesity and Health Practices | 2021-2025 | 16 | US 7 | 97.71 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 44 | US 21 | 98.95 |
| COVID-19 Clinical Research Studies | 2021-2025 | 337 | US 92 | 98.38 |
| Chronic Disease Management Strategies | 2021-2025 | 48 | US 7 | 97.84 |
| Heart Failure Treatment and Management | 2021-2025 | 70 | US 33 | 99.23 |
| Bariatric Surgery and Outcomes | 2021-2025 | 35 | US 13 | 98.19 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 92 | US 28 | 95.39 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 53 | US 33 | 96.60 |
| Nutrition and Health in Aging | 2021-2025 | 241 | US 32 | 96.94 |
| GDF15 and Related Biomarkers | 2021-2025 | 19 | US 4 | 92.25 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 444 | US 148 | 95.96 |
| Birth, Development, and Health | 2021-2025 | 370 | US 133 | 94.41 |
| Obesity, Physical Activity, Diet | 2021-2025 | 452 | US 116 | 95.51 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 35 | US 11 | 90.24 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 634 | US 223 | 91.32 |
| Genetic Associations and Epidemiology | 2021-2025 | 766 | US 332 | 87.92 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 620 | US 187 | 87.96 |
| Health, Environment, Cognitive Aging | 2021-2025 | 538 | US 240 | 84.11 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 646 | US 128 | 80.76 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 956 | US 207 | 77.02 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 879 | US 108 | 78.52 |
| Diabetes Management and Education | 2021-2025 | 878 | US 260 | 74.11 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 714 | US 255 | 66.28 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 664 | US 171 | 59.33 |
| Apelin-related biomedical research | 2021-2025 | 874 | US 135 | 23.48 |